Cannabidiol modulation of hippocampal glutamate in early psychosis
Abstract Background: Emerging evidence supports the antipsychotic effect of cannabidiol, a non-intoxicating component of cannabis, in people with psychosis. Preclinical…
Abstract Background: Emerging evidence supports the antipsychotic effect of cannabidiol, a non-intoxicating component of cannabis, in people with psychosis. Preclinical…
Abstract For a better translation from treatment designs of schizophrenia to clinical efficiency, there is a crucial need to refine…
Abstract Experimental evidence indicates that cannabidiol (CBD) induces anxiolytic and antiepileptic effects through the activation of 5-HT1A receptors. These receptors…
Abstract Background: Cannabidiol (CBD) is being investigated as a potential treatment for several medical indications, many of which are characterised…
Abstract During the last decades, researchers have investigated the functional relevance of adult hippocampal neurogenesis in normal brain function as…
Abstract Different studies have demonstrated that inflammation and alterations in glutamate neurotransmission are two events contributing to the pathophysiology of…
Abstract Oleoylethanolamide is an endogenous NAE that modulates ethanol-seeking behavior and ethanol-induced neuroinflammation. In the present study we further analyze…
Abstract Gene-targeted mice with deficient AMPA receptor GluA1 subunits (Gria1-/- mice) show robust hyperlocomotion in a novel environment, suggesting them…
Abstract Background and Aims: Legalization of cannabis (CB) for both medicinal and, in some states, recreational use, has given rise…
Abstract Marijuana is a widely used recreational drug with increasing legalization worldwide for medical purposes. Most experimental studies use either…